Eradication (zero cases worldwide) requires specific prerequisites: absence of animal reservoir (zoonotic diseases impossible to eradicate), availability of effective and practical intervention, R₀ amenable to control with available tools, and sustained political/economic commitment. Elimination (zero cases in specific regions) is achievable for more diseases. Only a few pathogens meet eradication criteria (smallpox succeeded; polio near success; measles eliminated regionally). Most disease control realistically aims for elimination or sustained low burden.
Compare requirements for eradication of three diseases: one successfully eradicated, one eliminated regionally, and one with zoonotic reservoir.
Using elimination and eradication synonymously—elimination is regional goal while eradication is global; eradication requires different conditions than elimination.
From your study of R₀ — the basic reproduction number — you know that a disease persists when R₀ > 1 and fades when effective transmission drops below that threshold. The herd immunity threshold (the fraction of a population that must be immune to halt transmission) is 1 − 1/R₀. For measles with an R₀ of ~15, about 93% of the population must be immune. For polio with R₀ ~5, roughly 80% coverage suffices. These numbers set the floor for what vaccination campaigns must achieve. But achieving and sustaining herd immunity at scale across national boundaries is very different from achieving it locally — and that difference is the gap between elimination (no ongoing transmission in a defined region) and eradication (zero cases globally, permanently, requiring no further intervention).
Smallpox succeeded as an eradication target because of a unique convergence of biological and logistical factors. The virus had no animal reservoir — it only circulated in humans, so stopping human transmission was sufficient. The vaccine was highly effective, heat-stable enough for use in the tropics, and conferred durable immunity. The disease was clinically obvious (the characteristic rash made cases easy to identify), enabling the ring vaccination strategy used in the final campaigns: instead of vaccinating everyone, teams vaccinated all contacts of identified cases, cutting off transmission chains. No other eradication campaign has faced all these conditions simultaneously.
Polio illustrates the obstacles. Oral polio vaccine (OPV) is cheap, easy to administer, and provides mucosal immunity that interrupts fecal-oral transmission — ideal properties. But OPV uses attenuated live virus, and in rare cases it reverts to virulence and causes vaccine-derived poliovirus (VDPV) outbreaks, particularly in under-immunized populations. The switch to inactivated polio vaccine (IPV) solves the reversion problem but provides weaker mucosal immunity, potentially allowing asymptomatic gut shedding even in vaccinated individuals. This biological complexity, combined with conflict zones that interrupt campaigns, has kept polio alive decades past its projected eradication date. The program remains the closest humanity has come to eradicating a second pathogen, but the last mile is the hardest.
Malaria illustrates why most diseases will never be candidates for eradication. Plasmodium parasites cycle through mosquito vectors and are maintained in non-human primate reservoirs (especially P. knowlesi in Southeast Asia). Even if every human case were eliminated, zoonotic reintroduction from animal hosts would restart transmission. Additionally, the parasite has an extraordinarily complex lifecycle spanning multiple biological stages in two hosts, making vaccine development difficult and drug resistance a persistent problem. For malaria and most other vector-borne and zoonotic diseases, realistic goals are control (reducing burden to acceptable levels) or regional elimination — achievable with sustained effort in specific settings, but not global eradication. Understanding these biological prerequisites before setting targets prevents the waste of resources on campaigns that cannot biologically succeed.
No topics depend on this one yet.